Skip to main content
. 2020 Mar 1;40(2):274–285. doi: 10.5851/kosfa.2020.e12

Fig. 2. Cell viability of RAW 264.7 cells treated with OVA and OVA hydrolysates.

Fig. 2.

■: 0.5 mg/mL, ▢: 1 mg/mL, □: 2 mg/mL. All values are represented as mean±SD of triplicate experiments. OVA, ovalbumin; OHMF, hydrolysates treated with Multifect 14L; OHPM, hydrolysates treated with Promod 278P; OHPT, hydrolysates treated with Protex 6L; OHT, hydrolysates treated with trypsin.